Emmetrope Ophthalmics LLC, (aka “Emmecell”) is a privately-held, clinical stage biotechnology company developing cell-based therapies. Emmecell’s platform technology leverages magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue. Our lead product EO2002 is a cell therapy for treatment for corneal edema, the most common indication for corneal transplantation. Cell Manufacturing and Production LLC (CellMP) was founded in 2018 and is a subsidiary of Emmecell providing GMP manufacturing services in Menlo Park, CA.
Looking for a particular Emmecell employee's phone or email?
Emmecell Questions
Ramin Valian is the CEO of Emmecell.
7 people are employed at Emmecell.
Emmecell is based in Menlo Park, California.
Top Emmecell Employees
-
Ramin Valian
Chief Executive Officer at Emmecell
Irvine, CA, US35+ -
Noelia Kunzevitzky
Chief Operating Officer at Emmecell
California, United States21 -
Christy Fleming
Director of Clinical Operations at Emmecell
Charlotte, NC, US42 -
Reza Bahranifard
Scientist at Emmecell
Menlo Park, CA, US3 -
Danielle Galindo
Quality Assurance Manager at Emmecell
California, United States12 -
Heather Elliott
Clinical Research Associate at Emmecell
Gardner, KS, US3 -
Kalisse Ajlouny
Research Associate at Emmecell
California, United States2
